Indefinite Delivery Contract SPE2DX15D7600

The federal contract IDV award SPE2DX15D7600 is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a total ceiling value of $4,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. It does not utilize any set-aside requirements, indicating open competition. The period of performance runs through December 31, 2025, with the place of performance located in Conshohocken, Pennsylvania.

The task orders issued under this IDC demonstrate Amerisourcebergen's role in delivering a diverse array of essential pharmaceutical and medical products to the DLA. These include deliveries of medications such as ciprofloxacin, dexamethasone, amoxicillin, and potassium clavulanate, as well as other injectable solutions and tablets. The firm-fixed-price delivery orders range in value from a few dollars to over $3,000, reflecting the varied medical needs served by this contract vehicle. This IDC enables the DLA to efficiently procure critical pharmaceutical and medical supplies to support the healthcare requirements of military personnel, veterans, and other federal beneficiaries.